Nalazite se na CroRIS probnoj okolini. Ovdje evidentirani podaci neće biti pohranjeni u Informacijskom sustavu znanosti RH. Ako je ovo greška, CroRIS produkcijskoj okolini moguće je pristupi putem poveznice www.croris.hr
izvor podataka: crosbi

Separation, Characterization and Quantification of Atorvastatin and Related Impurities by Liquid Chromatography-Electrospray Ionization Mass Spectrometry (CROSBI ID 158710)

Prilog u časopisu | izvorni znanstveni rad | međunarodna recenzija

Mornar, Ana ; Damić, Miranda ; Nigović, Biljana Separation, Characterization and Quantification of Atorvastatin and Related Impurities by Liquid Chromatography-Electrospray Ionization Mass Spectrometry // Analytical letters, 43 (2010), 18; 2859-2871. doi: 10.1080/00032711003763624

Podaci o odgovornosti

Mornar, Ana ; Damić, Miranda ; Nigović, Biljana

engleski

Separation, Characterization and Quantification of Atorvastatin and Related Impurities by Liquid Chromatography-Electrospray Ionization Mass Spectrometry

A method coupling high-performance liquid chromatography with diode-array detector and electrospray ionization mass spectrometry (HPLC-DAD-ESI/MSn) has been developed for the separation and characterization of atorvastatin and its related impurities. The results obtained using positive ion mode showed some diagnostic fragments which are useful for the identification of atorvastatin related impurities in real samples. Quantitative analysis of drug impurities was performed in the multiple reaction monitoring mode. Quantitation limits for impurities were in the ranges 21.5-70.8 ng mL-1. The method was successfully applied to the drug purity evaluation and quantitative determination of atorvastatin related impurities in bulk drugs and pharmaceutical formulations.

Atorvastatin; Electrospray ionization; Tandem mass spectrometry; Related impurities; Pharmaceuticals

nije evidentirano

nije evidentirano

nije evidentirano

nije evidentirano

nije evidentirano

nije evidentirano

Podaci o izdanju

43 (18)

2010.

2859-2871

objavljeno

0003-2719

10.1080/00032711003763624

Povezanost rada

Kemija, Farmacija

Poveznice
Indeksiranost